Heyao Wang
State Key Laboratory Of Drug Research
Shanghai, 201203, China
Shanghai, 201203, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Discovery of Potent and Selective FABP4/5 Inhibitors with an Isoquinolone Scaffold as Potential Therapeutics for Inflammation-Related Diseases.
Journal: Journal of medicinal chemistry
Published: September 24, 2025
Slow Metabolism-Driven Amplification of Hepatic PPARγ Agonism Mediates Benzbromarone-Induced Obesity-Specific Liver Injury.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 04, 2024
Optimization of potent, selective and orally bioavailable biphenyl scaffold as FABP4 inhibitors for anti-inflammation.
Journal: European journal of medicinal chemistry
Published: February 13, 2023
Vincamine as a GPR40 agonist improves glucose homeostasis in type 2 diabetic mice.
Journal: The Journal of endocrinology
Published: October 15, 2018
Discovery of novel selective GPR120 agonists with potent anti-diabetic activity by hybrid design.
Journal: Bioorganic & medicinal chemistry letters
Published: April 23, 2018
Repositioning organohalogen drugs: a case study for identification of potent B-Raf V600E inhibitors via docking and bioassay.
Journal: Scientific reports
Published: February 16, 2016
Preparation of Methylated Products of A-type Procyanidin Trimers in Cinnamon Bark and Their Protective Effects on Pancreatic β-Cell.
Journal: Journal of food science
Published: October 24, 2015
Inhibition of Calcium Influx Reduces Dysfunction and Apoptosis in Lipotoxic Pancreatic β-Cells via Regulation of Endoplasmic Reticulum Stress.
Journal: PloS one
Published: March 11, 2015
Design, Synthesis, and Pharmacological Evaluation of Fused β-Homophenylalanine Derivatives as Potent DPP-4 Inhibitors.
Journal: ACS medicinal chemistry letters
Published: February 15, 2015
Design, synthesis, and structure-activity and structure-pharmacokinetic relationship studies of novel [6,6,5] tricyclic fused oxazolidinones leading to the discovery of a potent, selective, and orally bioavailable FXa inhibitor.
Journal: Journal of medicinal chemistry
Published: September 03, 2014
Novel fatty acid binding protein 4 (FABP4) inhibitors: virtual screening, synthesis and crystal structure determination.
Journal: European journal of medicinal chemistry
Published: July 03, 2014
Last Updated: 09/26/2026